NRG-GU006 trial for post-prostatectomy radiation therapy. Daniel Spratt, MD Case Comprehensive Cancer Center joins Jeff Michalski, MD, MBA, FACR, FASTRO Washington University in St. Louis to present the NRG GU006/BALANCE trial results, demonstrating PAM50 molecular subtypes as the first prospectively validated predictive biomarker guiding hormone therapy decisions in recurrent #ProstateCancer. #WatchNow on UroToday > bit.ly/4mONYa3 | UroToday

20K views · 121 reactions | Pres. #Trump honored D.J. Daniel, a 13-year-old boy who has battled brain cancer for most of his life, by making him an honorary Secret Service agent. This gesture was part of a presidential address to Congress, highlighting D.J’s dream to become a police officer despite his health challenges. The ceremony included Secret Service Director Sean Curran officially recognizing D.J. #fyp #trump | Jay Williams | Facebook